期刊文献+

胰腺癌胰液肽表达谱变化的分析

Peptideomic analysis of pancreatic juice from pancreatic cancer and cancer-free controls
下载PDF
导出
摘要 目的:分析正常胰液与胰腺癌胰液多肽表达谱的差异。方法:用ZipTipC18提取胰液样品多肽,采用基质辅助激光解析离子化飞行时间/飞行时间质谱技术(MALDITOF/TOFMS)对胰液的多肽表达谱进行肽质量指纹图谱(PMF)分析,对获得的数据进行标准化处理,对高丰度的差异肽段进行TOF/TOF分析,建立胰腺癌胰液的诊断模型。结果:通过质谱分析,得到了反映胰腺癌胰液多肽组成的特征图谱,通过TOF/TOF分析,一个胰腺癌胰液相关的肽段鉴定为fibrinogenα链前体,氨基酸序列为DS-GEGDFLAEGGGVR。结论:ZipTipC18富集胰液样品后直接进行MALDI-TOF/TOFMS分析的技术,可应用于快速扫描与胰腺癌有关的多肽表达谱,建立胰腺癌胰液的多肽诊断模型,具有较好的临床应用价值。 OBJECTIVE: To analyze the differential peptidomic profiles of pancreatic fluids between normal control and tumor. METHODS: Samples were handled directly by ZipTip C18 and PMF analysis was performed by MALDI TOF/TOF MS. The acquired data was standardized and peptides of interest was identified by TOF/TOF analysis. RESULTS: The peptidomic profiles which reflected the protein composition was acquired by MS analysis. By means of TOF/TOF analysis, one peptide in the pancreatic fluid from tumor was identified as fibrinogen α chain precursor. CONCLUSIONS: The method that samples was enriched by Zip Tip C18 and followed by MALDI-TOF/TOF MS analysis, allows the fast screen of potential peptide/protein markers in the body fluid. The peptidomic profiles were built for the diagnosis of pancreatic cancer and its implications for diagnostics are far-reaching.
出处 《中华肿瘤防治杂志》 CAS 2008年第15期1144-1146,1154,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 山东省重大科技攻关专项(2005GG1102003)
关键词 胰腺肿瘤 胰液 多肽表达谱 光谱分析 质量 pancreatic neoplasms pancreatic juice peptidomic profiles spectrum analysis, mass
  • 相关文献

参考文献11

  • 1Perkins D N, Pappin D J, Creasy D M, et al. Probability based protein identification by searching sequence databases using mass spectrometrydata[J]. Electrophoresis, 1999, 20:3551-67.
  • 2Gogichaeva N V. Williams T, Alterman M A, et al. MALDI TOF/ TOF tandem mass spectrometry as a new tool for amino acid analysis [J]. J Am Soc Mass Spectrom. 2007.18(2):279-84.
  • 3Cotter R J, Griffffith W, Jelinek C, et al. Tandem time-of-flight (TOF/TOF) mass spectrometry and the curved-field refflectron [J]. J Chromatogr B Analyt Technol Biomed Lille Sci, 2007, 855(1):2-13.
  • 4Falkner J A, Kachman M, Veine D M, et al. Validated MALDI-TOF/TOFmass spectra for protein standards[J]. J Am Soc Mass Spectrom. 2007.18(5) :850-5.
  • 5Villanueva J, Shaffer D R, Philip J, et al. Differential exoprotease activities confer tumor specific serum peptidome patterns [J]. J Clin Invest, 2006, 116:271-284.
  • 6Lopez M F, Mikulskis A, Kuzdzal S, et al. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease specific, carrier-protein-bound mass signatures[J]. Clin Chem, 2005, 51(10) :1946-1954.
  • 7Lowenthal M S, Mehta A I, Frogale K, et al. Analysis of albumin associated peptides and proteins from ovarian cancer patients [J]. Clin Chem, 2005,51:1933-1945.
  • 8Petricoin E F, Fishman D A, Conrads T P, et al. Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics[J]. Proteomics, 2004, 4 (8) : 2357-2360.
  • 9Tirumalai R S, Chan K C, Prieto D A, et al. Characterization of the low molecular weight human serum proteome[J]. Mol Cell Proteomics, 2003, 2(10) : 1096-1103.
  • 10Brouwers F M, Petricoin E F, Ksinantova L, et al. Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma [J]. Endocr Relat Cancer, 2005, 12(2):263-272.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部